The first stop for professional medicines advice

Tacrolimus

Published
Topics: Allergy and immunologyCancersPatent expiries · Safety in BreastfeedingSkin disordersStability in dosette boxesTacrolimus ·
Contents
  1. dm+d
  2. Articles
  3. Medicine Compliance Aid Stability
    1. Prograf · Astellas Pharma Ltd
    2. Advagraf · Astellas Pharma Ltd
    3. Capexion · Generics UK Ltd
    4. Tacni · Teva UK Ltd
    5. Envarsus · Chiesi Ltd
  4. Lactation Safety Information
    1. Oral / Parenteral
    2. For topical use

dm+d

109129008

Articles

Specific medicine switches for solid dose and liquid formulations

13 September 2023

Example medicines to prescribe by brand name in primary care

27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.

Tacrolimus monitoring

14 July 2021
Search Articles

Medicine Compliance Aid Stability

PrografAstellas Pharma Ltd

Astellas Pharma Ltd
Prograf
Capsules 500 micrograms, 1mg, 5mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Keep in original package to protect from moisture. Unsuitable.
22 December 2022
Usage of Medicines in Compliance Aids

AdvagrafAstellas Pharma Ltd

Astellas Pharma Ltd
Advagraf
Capsules m/r 500 micrograms, 1mg, 3mg, 5mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Keep in original package to protect from moisture
23 November 2022
Usage of Medicines in Compliance Aids

CapexionGenerics UK Ltd

Generics UK Ltd
Capexion
Capsules 500micrograms, 1mg, 5mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Soft capsule. Protect from light and moisture.
23 November 2022
Usage of Medicines in Compliance Aids

TacniTeva UK Ltd

Teva UK Ltd
Tacni
Capsules 500micrograms, 1mg, 5mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soft capsule. Protect from light and moisture. Unsuitable.
22 December 2022
Usage of Medicines in Compliance Aids

EnvarsusChiesi Ltd

Chiesi Ltd
Envarsus
Capsules m/r 750micrograms, 1mg, 4mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Soft capsule. Shelf life of 45 days once foil strip opened. Protect from light.
23 November 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Oral / Parenteral

Oral / Parenteral
Yes
See summary
Significant published evidence of safety
Small amounts in breast milk
Monitor infant plasma levels if there is a concern about toxicity
15 September 2019
Bibliography

For topical use

For topical use
Yes
Indicated for moderate-severe atopic eczema/ facial, flexor & genital psoriasis
See summary for specific comments
Safety in Lactation: Topical preparations for eczema and psoriasis
15 September 2019
Bibliography